Back to Search
Start Over
[Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation?]
- Source :
-
Therapeutische Umschau. Revue therapeutique [Ther Umsch] 2022 Aug; Vol. 79 (6), pp. 285-288. - Publication Year :
- 2022
-
Abstract
- Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation? Abstract. Hypogammaglobulinemias occur in people with multiple sclerosis (MS) without immunotherapy in 8.1% of patients and with immunotherapy (not drug-specific) in up to 26.4% of affected individuals. This is thus significantly higher than the expected incidence in the general population. In MS patients it is also relevant to differentiate between primary and secondary hypogammaglobulinemia. In particular, anti-CD20 therapies are mainly underlying for the secondary forms in MS patients. With this article, we aim to provide a "spotlight" on hypogammaglobulinemia with a focus on the clinical consequence of these phenomena in people with MS.
Details
- Language :
- German
- ISSN :
- 0040-5930
- Volume :
- 79
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Therapeutische Umschau. Revue therapeutique
- Publication Type :
- Academic Journal
- Accession number :
- 35903830
- Full Text :
- https://doi.org/10.1024/0040-5930/a001362